Introduction
Hyponatraemia, serum sodium < 135mmol/l, is the commonest electrolyte imbalance encountered in clinical practice (1). Prevalence is known to increase in frail patient groups. Elderly patients with fragility fractures (EPFF) are particularly susceptible to hyponatraemia and are at higher risk of complications, making this a group of special clinical importance (1, 2). Hyponatraemia occurs due to disruption of sodium and water homeostasis, normally maintained by complex multi-system physiological mechanisms (1). Consequently, there are numerous potential underlying causes of hyponatraemia, spanning a broad spectrum of diseases, pharmacotherapy and pathophysiological variants each with different treatment requirements (see figure 1) (3).
Hyponatraemia is associated with geriatric conditions and multi-organ pathological changes. these include abnormal gait patterns, falls, fractures, cognitive impairment, bone demineralisation, longer hospital stay, institutionalisation and increased mortality (2-7). Whether it is an independent predictor of patient outcomes or a marker of disease severity is debatable (3). nevertheless, hyponatraemia is very treatable, so its association with multiple poor clinical outcomes is important.
Clinical management of hyponatraemia is based on diagnosing and treating the underlying causes and restoring salt and water balance (1). However, accurate determination of aetiology of hyponatraemia is notoriously challenging (8). Diagnosis depends crucially on accurate assessment of volaemic status which is difficult to determine with certainty, especially in older individuals for whom there is currently no reliable biomarker of hydration (3, 9). Expert physicians' clinical judgment is the most widely accepted means of obtaining an accurate diagnosis. Diagnostic algorithms have been developed to facilitate clinical management of hyponatraemia by non-specialist clinicians, but all rely on accurate assessment of volaemic status (10). standard assessment of volaemic status, using clinical examination, is unreliable for older hyponatraemic patients (8). moreover, hyponatraemia in older individuals is predominantly multifactorial in aetiology, and may therefore present with conflicting signs of volaemic status (7, 11 requires strict fluid restriction whilst dehydration requires vigorous fluid replacement). given the probability of degenerative physiology with concomitant disease in older individuals, there is little room for treatment error, particularly in EPFF who endure additional homeostatic challenges due to the fracture and subsequent surgical intervention (12). in order to improve clinical management and outcomes of hyponatraemia, a reliable biomarker of hydration in older individuals is urgently required (3). Previous work suggests that knowledge of tBW may be useful (8). inter-person variability of tBW is large, so single readings of tBW are unlikely to be of clinically utility. However, intra-person variability is low (i.e. an individual's tBW changes little day-to-day in health) (13). Repeated intra-subject measures of tBW may therefore be beneficial in determining volaemic state of hyponatraemia when accompanied by changes in serum sodium levels (8). the gold standard for measuring tBW, isotope dilutional analysis, is currently too expensive and difficult to obtain for routine clinical use. However, bioelectrical impedance analysis (Bia) is a simple, non-invasive, cheap and rapid measure of tBW which has been validated for use in acutely ill elderly hyonatramic patients (8, 14) . it relies on the principle that the reciprocal of the impedance opposed to a weak alternating current applied across the body is proportional to tBW (15). using age-sex specific calculations, tBW can be obtained from impedance measurements, height and weight (16). Despite its' clinical practicality, the utility of Bia in clinical management of hyponatraemia has never been investigated. this study is the first to establish the potential clinical utility of Bia in EPFF as a marker of volaemic status.
Methods
We conducted an observational study in consenting adults aged 65 years and above admitted with a fragility fracture to aberdeen Royal infirmary, a university teaching hospital, from 7th January -4th april 2013. Fragility fractures were defined as those occurring either without trauma or due to low energy trauma, equivalent to a fall from standing height or less than one metre. adults with incapacity were excluded from 
